ProKidney’s stock rockets on ‘intriguing’ news, but analyst doesn’t recommend buying

marketwatch.com/story/prokidneys-stock-rockets-on-intriguing-news-but-analyst-doesnt-recommend-buying-19ce3f45

ProKidney’s stock was the biggest gainer and most actively traded on Tuesday following “very intriguing” news regarding the biotech’s CKD and diabetes treatment.

This story appeared on marketwatch.com, 2025-07-08 21:09:00.
The Entire Business World on a Single Page. Free to Use →